SpectraCure raises approximately SEK 140 million through a fully subscribed rights issue
SpectraCure AB’s (publ) (Nasdaq First North Premier Growth Market: SPEC) (“SpectraCure” or the “Company”) fully guaranteed new Units issue with preferential rights for the Company’s existing shareholders (the “Rights Issue”), was fully subscribed. Through the Rights Issue, SpectraCure will receive proceeds amounting to approximately SEK 140 million before transaction costs.Not for publication, distribution or release, directly or indirectly, in whole or in part, within or into the US, Canada, Japan, Australia, Hong Kong, New Zeeland or any other jurisdiction in which such publication,